Michal Barzily-Rokni
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Michal Barzily-Rokni has a total of 104 co-authors. Here are the top co-authors by number of shared publications:
- Dennie T. Frederick
Broad Institute
19 shared publications - Keith T. Flaherty
Massachusetts General Hospital, Boston, MA
19 shared publications Aurelie Beroard
16 shared publicationsBenchun Miao
16 shared publications- Bradley Garman
Division of Translational Medicine and Human Genetics, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA
16 shared publications - Bradley Wubbenhorst
Division of Translational Medicine and Human Genetics and
16 shared publications
Latest Publications
- Open Access
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Tables S1-S2 from A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
PDF file 89K, This file contains a table listing the top 75 genes correlated with RAF-inhibitor sensitivity in BRAFV600E-mutant cell lines as well as a table describing the IHC results summarized in Main Figure 2b and 2c
- 3 April 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Tables S1-S2 from A Melanoma Cell State Distinction Influences Sensitivity to MAPK Pathway Inhibitors
PDF file 89K, This file contains a table listing the top 75 genes correlated with RAF-inhibitor sensitivity in BRAFV600E-mutant cell lines as well as a table describing the IHC results summarized in Main Figure 2b and 2c
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Movie S3 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessMovie S3 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Movie S4 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2)-BR cells treated with 6-thio-dG.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessMovie S4 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2)-BR cells treated with 6-thio-dG.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Movie S4 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2)-BR cells treated with 6-thio-dG.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessMovie S4 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2)-BR cells treated with 6-thio-dG.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Movie S5 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2)-CR cells treated with the control.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessMovie S5 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2)-CR cells treated with the control.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Data from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessData from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Movie S6 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2)-CR cells treated with 6-thio-dG.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessMovie S6 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2)-CR cells treated with 6-thio-dG.
- Open Access
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Movie S2 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2) cells treated with 6-thio-dG.
- 31 March 2023
- Published by American Association for Cancer Research (AACR)
Open AccessMovie S2 from Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Time-lapse imaging of A375(Fucci2) cells treated with 6-thio-dG.